Trials / Recruiting
RecruitingNCT06088277
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
Texting in Community Health Center Dental Clinics to Reduce HIV Risk
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 266 (estimated)
- Sponsor
- Boston University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a 3-year study to test the efficacy of a text message-based intervention program. Dental patients at 4 community health centers (n= 266) will be randomized to receive either text messages (TMs) regarding HIV prevention or TMs regarding overall wellness. Prior to enrolling the 266 participants, the investigators will conduct a feasibility pilot (n=20) to test the TM delivery as well as all study procedures. For both the pilot and the randomized clinical trial (RCT), recruitment will be conducted at 4 Community Health Center dental clinics (Codman Square, East Boston (both East Boston and South End locations), Geiger Gibson, and Upham's Community Health Centers). Recruitment materials (flyers and permission to contact forms) may also be made available at other clinics within the health centers. The study will enroll English and Spanish-speaking patients who have at least one risk factor for HIV but are HIV-negative. Patients enrolled in the pilot will complete self-report surveys at baseline, 1 and 2 months. Participants enrolled in the RCT will complete self-report surveys baseline, 3, 6, and 12 months after baseline; receive and respond to TM assessments during the 6-month intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | TM HIV | Participants will receive 5 intervention text messages (TM) about HIV risk and testing per week for the first 3 months and 3 messages per week for the last 3 months of the intervention. |
| BEHAVIORAL | TM HL | Participants will receive 5 intervention text messages (TM) about promoting healthy living (HL) per week for the first 3 months and 3 messages per week for the last 3 months of the intervention. |
Timeline
- Start date
- 2024-08-16
- Primary completion
- 2027-04-14
- Completion
- 2027-04-14
- First posted
- 2023-10-18
- Last updated
- 2025-07-30
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06088277. Inclusion in this directory is not an endorsement.